Skip to main content
Reevaluating Adjuvant Capecitabine for Resected Biliary Tract Cancer
Published Web Location
https://doi.org/10.1093/oncolo/oyad202Abstract
Highlighting concerns about the acceptance of oncologic therapies with no proven benefit, this article compares the interpretation of the clinical trial results of several studies conducted to identify a better therapy for patients with biliary tract cancer.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.